 | • レポートコード：B-GIR08C4886 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、組み換え抗体の世界市場について調べ、まとめました。種類別セグメントは、キメラ抗体、ヒト化抗体、完全ヒト抗体、一本鎖抗体、二重特異性抗体等、用途別セグメントは、病院、科学研究、その他等に区分しました。組み換え抗体の世界市場概観、企業動向、企業別組み換え抗体シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・組み換え抗体の市場概観 ・組み換え抗体の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・組み換え抗体の企業別販売動向、市場シェア、市場集中度、競争動向 ・組み換え抗体の世界市場規模 ・組み換え抗体の北米市場分析（アメリカ、カナダ、メキシコ等） ・組み換え抗体のアメリカ市場規模推移 ・組み換え抗体のカナダ市場規模推移 ・組み換え抗体のメキシコ市場規模推移 ・組み換え抗体のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・組み換え抗体のドイツ市場規模推移 ・組み換え抗体のイギリス市場規模推移 ・組み換え抗体のロシア市場規模推移 ・組み換え抗体のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・組み換え抗体の日本市場規模推移 ・組み換え抗体の中国市場規模推移 ・組み換え抗体の韓国市場規模推移 ・組み換え抗体のインド市場規模推移 ・組み換え抗体の東南アジア市場規模推移 ・組み換え抗体の南米市場分析（ブラジル、アルゼンチン等） ・組み換え抗体の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・組み換え抗体の種類別分析/販売量、売上、市場シェア（キメラ抗体、ヒト化抗体、完全ヒト抗体、一本鎖抗体、二重特異性抗体） ・組み換え抗体の用途別分析/市場規模（病院、科学研究、その他） ・組み換え抗体の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・組み換え抗体の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Recombinant Antibody is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Recombinant Antibody in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
Market Segment by Applications, can be divided into
Hospital
Scientific Research
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Antibody, with price, sales, revenue and global market share of Recombinant Antibody in 2017 and 2018.
Chapter 3, the Recombinant Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Recombinant Antibody market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Recombinant Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Chimeric Antibody
1.2.2 Humanized Antibody
1.2.3 Full Human Antibody
1.2.4 Single Chain Antibody
1.2.5 Bispecific Antibody
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Scientific Research
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abnova
2.1.1 Business Overview
2.1.2 Recombinant Antibody Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abnova Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Medix Biochemica
2.2.1 Business Overview
2.2.2 Recombinant Antibody Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medix Biochemica Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GE Healthcare
2.3.1 Business Overview
2.3.2 Recombinant Antibody Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GE Healthcare Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 SinoBiological
2.4.1 Business Overview
2.4.2 Recombinant Antibody Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SinoBiological Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bioventix
2.5.1 Business Overview
2.5.2 Recombinant Antibody Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bioventix Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Recombinant Antibody Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Recombinant Antibody Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Recombinant Antibody Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Antibody Manufacturer Market Share in 2018
3.3.2 Top 6 Recombinant Antibody Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Recombinant Antibody Market Analysis by Regions
4.1 Global Recombinant Antibody Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Antibody Sales and Market Share by Regions (2014-2019)
4.1.2 Global Recombinant Antibody Revenue and Market Share by Regions (2014-2019)
4.2 North America Recombinant Antibody Sales and Growth Rate (2014-2019)
4.3 Europe Recombinant Antibody Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Recombinant Antibody Sales and Growth Rate (2014-2019)
4.5 South America Recombinant Antibody Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Recombinant Antibody Sales and Growth Rate (2014-2019)
5 North America Recombinant Antibody by Country
5.1 North America Recombinant Antibody Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Antibody Sales and Market Share by Country (2014-2019)
5.1.2 North America Recombinant Antibody Revenue and Market Share by Country (2014-2019)
5.2 United States Recombinant Antibody Sales and Growth Rate (2014-2019)
5.3 Canada Recombinant Antibody Sales and Growth Rate (2014-2019)
5.4 Mexico Recombinant Antibody Sales and Growth Rate (2014-2019)
6 Europe Recombinant Antibody by Country
6.1 Europe Recombinant Antibody Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Antibody Sales and Market Share by Country (2014-2019)
6.1.2 Europe Recombinant Antibody Revenue and Market Share by Country (2014-2019)
6.2 Germany Recombinant Antibody Sales and Growth Rate (2014-2019)
6.3 UK Recombinant Antibody Sales and Growth Rate (2014-2019)
6.4 France Recombinant Antibody Sales and Growth Rate (2014-2019)
6.5 Russia Recombinant Antibody Sales and Growth Rate (2014-2019)
6.6 Italy Recombinant Antibody Sales and Growth Rate (2014-2019)
7 Asia-Pacific Recombinant Antibody by Country
7.1 Asia-Pacific Recombinant Antibody Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Recombinant Antibody Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Recombinant Antibody Revenue and Market Share by Country (2014-2019)
7.2 China Recombinant Antibody Sales and Growth Rate (2014-2019)
7.3 Japan Recombinant Antibody Sales and Growth Rate (2014-2019)
7.4 Korea Recombinant Antibody Sales and Growth Rate (2014-2019)
7.5 India Recombinant Antibody Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Recombinant Antibody Sales and Growth Rate (2014-2019)
8 South America Recombinant Antibody by Country
8.1 South America Recombinant Antibody Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Antibody Sales and Market Share by Country (2014-2019)
8.1.2 South America Recombinant Antibody Revenue and Market Share by Country (2014-2019)
8.2 Brazil Recombinant Antibody Sales and Growth Rate (2014-2019)
8.3 Argentina Recombinant Antibody Sales and Growth Rate (2014-2019)
8.4 Colombia Recombinant Antibody Sales and Growth Rate (2014-2019)
9 Middle East and Africa Recombinant Antibody by Countries
9.1 Middle East and Africa Recombinant Antibody Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Recombinant Antibody Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Recombinant Antibody Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Recombinant Antibody Sales and Growth Rate (2014-2019)
9.3 Turkey Recombinant Antibody Sales and Growth Rate (2014-2019)
9.4 Egypt Recombinant Antibody Sales and Growth Rate (2014-2019)
9.5 Nigeria Recombinant Antibody Sales and Growth Rate (2014-2019)
9.6 South Africa Recombinant Antibody Sales and Growth Rate (2014-2019)
10 Global Recombinant Antibody Market Segment by Type
10.1 Global Recombinant Antibody Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Recombinant Antibody Sales and Market Share by Type (2014-2019)
10.1.2 Global Recombinant Antibody Revenue and Market Share by Type (2014-2019)
10.2 Chimeric Antibody Sales Growth and Price
10.2.1 Global Chimeric Antibody Sales Growth (2014-2019)
10.2.2 Global Chimeric Antibody Price (2014-2019)
10.3 Humanized Antibody Sales Growth and Price
10.3.1 Global Humanized Antibody Sales Growth (2014-2019)
10.3.2 Global Humanized Antibody Price (2014-2019)
10.4 Full Human Antibody Sales Growth and Price
10.4.1 Global Full Human Antibody Sales Growth (2014-2019)
10.4.2 Global Full Human Antibody Price (2014-2019)
10.5 Single Chain Antibody Sales Growth and Price
10.5.1 Global Single Chain Antibody Sales Growth (2014-2019)
10.5.2 Global Single Chain Antibody Price (2014-2019)
10.6 Bispecific Antibody Sales Growth and Price
10.6.1 Global Bispecific Antibody Sales Growth (2014-2019)
10.6.2 Global Bispecific Antibody Price (2014-2019)
11 Global Recombinant Antibody Market Segment by Application
11.1 Global Recombinant Antibody Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Scientific Research Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Recombinant Antibody Market Forecast (2019-2024)
12.1 Global Recombinant Antibody Sales, Revenue and Growth Rate (2019-2024)
12.2 Recombinant Antibody Market Forecast by Regions (2019-2024)
12.2.1 North America Recombinant Antibody Market Forecast (2019-2024)
12.2.2 Europe Recombinant Antibody Market Forecast (2019-2024)
12.2.3 Asia-Pacific Recombinant Antibody Market Forecast (2019-2024)
12.2.4 South America Recombinant Antibody Market Forecast (2019-2024)
12.2.5 Middle East and Africa Recombinant Antibody Market Forecast (2019-2024)
12.3 Recombinant Antibody Market Forecast by Type (2019-2024)
12.3.1 Global Recombinant Antibody Sales Forecast by Type (2019-2024)
12.3.2 Global Recombinant Antibody Market Share Forecast by Type (2019-2024)
12.4 Recombinant Antibody Market Forecast by Application (2019-2024)
12.4.1 Global Recombinant Antibody Sales Forecast by Application (2019-2024)
12.4.2 Global Recombinant Antibody Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Recombinant Antibody Picture
Table Product Specifications of Recombinant Antibody
Figure Global Sales Market Share of Recombinant Antibody by Types in 2018
Table Recombinant Antibody Types for Major Manufacturers
Figure Chimeric Antibody Picture
Figure Humanized Antibody Picture
Figure Full Human Antibody Picture
Figure Single Chain Antibody Picture
Figure Bispecific Antibody Picture
Figure Recombinant Antibody Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Scientific Research Picture
Figure Others Picture
Figure United States Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure France Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure UK Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure China Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure India Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Recombinant Antibody Revenue (Value) and Growth Rate (2014-2024)
Table Abnova Basic Information, Manufacturing Base and Competitors
Table Abnova Recombinant Antibody Type and Applications
Table Abnova Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Medix Biochemica Basic Information, Manufacturing Base and Competitors
Table Medix Biochemica Recombinant Antibody Type and Applications
Table Medix Biochemica Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Recombinant Antibody Type and Applications
Table GE Healthcare Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table SinoBiological Basic Information, Manufacturing Base and Competitors
Table SinoBiological Recombinant Antibody Type and Applications
Table SinoBiological Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bioventix Basic Information, Manufacturing Base and Competitors
Table Bioventix Recombinant Antibody Type and Applications
Table Bioventix Recombinant Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Recombinant Antibody Sales by Manufacturer (2017-2018)
Figure Global Recombinant Antibody Sales Market Share by Manufacturer in 2017
Figure Global Recombinant Antibody Sales Market Share by Manufacturer in 2018
Table Global Recombinant Antibody Revenue by Manufacturer (2017-2018)
Figure Global Recombinant Antibody Revenue Market Share by Manufacturer in 2017
Figure Global Recombinant Antibody Revenue Market Share by Manufacturer in 2018
Figure Top 3 Recombinant Antibody Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Recombinant Antibody Manufacturer (Revenue) Market Share in 2018
Figure Global Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Global Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table Global Recombinant Antibody Sales by Regions (2014-2019)
Table Global Recombinant Antibody Sales Market Share by Regions (2014-2019)
Table Global Recombinant Antibody Revenue by Regions (2014-2019)
Figure Global Recombinant Antibody Revenue Market Share by Regions in 2014
Figure Global Recombinant Antibody Revenue Market Share by Regions in 2018
Figure North America Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure South America Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure North America Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table North America Recombinant Antibody Sales by Countries (2014-2019)
Table North America Recombinant Antibody Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Antibody Sales Market Share by Countries in 2014
Figure North America Recombinant Antibody Sales Market Share by Countries in 2018
Table North America Recombinant Antibody Revenue by Countries (2014-2019)
Table North America Recombinant Antibody Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Antibody Revenue Market Share by Countries in 2014
Figure North America Recombinant Antibody Revenue Market Share by Countries in 2018
Figure United States Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Canada Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Mexico Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table Europe Recombinant Antibody Sales by Countries (2014-2019)
Table Europe Recombinant Antibody Sales Market Share by Countries (2014-2019)
Table Europe Recombinant Antibody Revenue by Countries (2014-2019)
Figure Europe Recombinant Antibody Revenue Market Share by Countries in 2017
Figure Europe Recombinant Antibody Revenue Market Share by Countries in 2018
Figure Germany Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure UK Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure France Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Russia Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Italy Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Recombinant Antibody Sales by Countries (2014-2019)
Table Asia-Pacific Recombinant Antibody Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Recombinant Antibody Sales Market Share by Countries 2018
Table Asia-Pacific Recombinant Antibody Revenue by Countries (2014-2019)
Figure Asia-Pacific Recombinant Antibody Revenue Market Share by Countries 2018
Figure China Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Japan Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Korea Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure India Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Southeast Asia Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure South America Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table South America Recombinant Antibody Sales by Countries (2014-2019)
Table South America Recombinant Antibody Sales Market Share by Countries (2014-2019)
Figure South America Recombinant Antibody Sales Market Share by Countries in 2018
Table South America Recombinant Antibody Revenue by Countries (2014-2019)
Table South America Recombinant Antibody Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Antibody Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Argentina Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Colombia Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Antibody Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Recombinant Antibody Sales by Countries (2014-2019)
Table Middle East and Africa Recombinant Antibody Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Antibody Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Antibody Revenue by Countries (2014-2019)
Table Middle East and Africa Recombinant Antibody Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Antibody Revenue Market Share by Countries in 2014
Figure Middle East and Africa Recombinant Antibody Revenue Market Share by Countries in 2018
Figure Saudi Arabia Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure UAE Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Egypt Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure Nigeria Recombinant Antibody Sales and Growth Rate (2014-2019)
Figure South Africa Recombinant Antibody Sales and Growth Rate (2014-2019)
Table Global Recombinant Antibody Sales by Type (2014-2019)
Table Global Recombinant Antibody Sales Share by Type (2014-2019)
Table Global Recombinant Antibody Revenue by Type (2014-2019)
Table Global Recombinant Antibody Revenue Share by Type (2014-2019)
Figure Global Chimeric Antibody Sales Growth (2014-2019)
Figure Global Chimeric Antibody Price (2014-2019)
Figure Global Humanized Antibody Sales Growth (2014-2019)
Figure Global Humanized Antibody Price (2014-2019)
Figure Global Full Human Antibody Sales Growth (2014-2019)
Figure Global Full Human Antibody Price (2014-2019)
Figure Global Single Chain Antibody Sales Growth (2014-2019)
Figure Global Single Chain Antibody Price (2014-2019)
Figure Global Bispecific Antibody Sales Growth (2014-2019)
Figure Global Bispecific Antibody Price (2014-2019)
Table Global Recombinant Antibody Sales by Application (2014-2019)
Table Global Recombinant Antibody Sales Share by Application (2014-2019)
Figure Global Scientific Research Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Recombinant Antibody Sales, Revenue and Growth Rate (2019-2024)
Table Global Recombinant Antibody Sales Forecast by Regions (2019-2024)
Table Global Recombinant Antibody Market Share Forecast by Regions (2019-2024)
Figure North America Sales Recombinant Antibody Market Forecast (2019-2024)
Figure Europe Sales Recombinant Antibody Market Forecast (2019-2024)
Figure Asia-Pacific Sales Recombinant Antibody Market Forecast (2019-2024)
Figure South America Sales Recombinant Antibody Market Forecast (2019-2024)
Figure Middle East and Africa Sales Recombinant Antibody Market Forecast (2019-2024)
Table Global Recombinant Antibody Sales Forecast by Type (2019-2024)
Table Global Recombinant Antibody Market Share Forecast by Type (2019-2024)
Table Global Recombinant Antibody Sales Forecast by Application (2019-2024)
Table Global Recombinant Antibody Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のモノクローナル抗体療法市場：市場規模・現状・予測 Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…- ウサギ抽出抗DPH5抗体の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Anti-DPH5 Antibody Produced In Rabbit market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 多発性骨髄腫に対するモノクローナル抗体の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Monoclonal Antibody for Multiple Myeloma market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espec…
- GNSグルコサミン（GNS抗体）市場：世界及び中国市場分析・予測（～2024年） GNS Glucosamine(GNS Antibody) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global GNS Glucosamine(GNS Antibody) industry with a focus on the Chinese market. The report provides key statistics on the market status of the GNS Glucos…
- EXTL2抗体市場：世界及び中国市場分析・予測（～2024年） EXTL2 Antibody Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global EXTL2 Antibody industry with a focus on the Chinese market. The report provides key statistics on the market status of the EXTL2 Antibody manufacturers and is a va…